THROMBOTIC MICROANGIOPATHY

Clinical trials for THROMBOTIC MICROANGIOPATHY explained in plain language.

Never miss a new study

Get alerted when new THROMBOTIC MICROANGIOPATHY trials appear

Sign up with your email to follow new studies for THROMBOTIC MICROANGIOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 2 Completed 1

New oral drug trial aims to save lives from dangerous transplant complication

Disease control Not yet recruiting

This study is testing an oral medication called iptacopan for patients who develop a serious, high-risk blood clotting complication after a stem cell transplant. The trial will enroll 30 participants who have not responded to initial treatments. Researchers want to see if iptacop…

Matched conditions: THROMBOTIC MICROANGIOPATHY

Phase: NA • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

THROMBOTIC MICROANGIOPATHY

Get alerted when new THROMBOTIC MICROANGIOPATHY trials appear

New oral drug trial aims to save lives from dangerous transplant complication